Putnam Investments LLC Amicus Therapeutics, Inc. Transaction History

Putnam Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $1.67 Million - $2.75 Million	-207,628 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1,490 - $1,958	136 Added 0.07%	207,628 $2.59 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $1.42 Million - $2.03 Million	122,614 Added 144.46%	207,492 $2.51 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $19,064 - $24,814	-1,452 Reduced 1.68%	84,878 $1.33 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.19 Million - $1.48 Million	86,330 New	86,330 $1.3 Million

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.